Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;105(6):1537-1546.e8.
doi: 10.1016/j.fertnstert.2016.02.011. Epub 2016 Mar 21.

Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome?

Affiliations

Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome?

Nicole Banks et al. Fertil Steril. 2016 Jun.

Abstract

Objective: To study a broad range of FMR1 CGG repeat lengths and assisted reproduction technology (ART) outcomes.

Design: Retrospective cohort study.

Setting: Private ART practice.

Patient(s): Fresh autologous ART stimulation cycles.

Intervention(s): None.

Main outcome measure(s): Oocyte yield, live birth.

Result(s): We screened 14,088 fresh autologous ART cycles from 2012 to 2015, of which 4,690 cycles in 3,290 patients met the inclusion criteria. The FMR1 repeat length was statistically significantly but weakly associated with oocyte yield and other markers of ovarian response. The receiver operating characteristic curve analysis suggested extremely limited predictive ability. Moreover, the FMR1 repeat length was not statistically significantly associated with outcomes in multivariable models, including other markers of ovarian reserve. The FMR1 repeat length was not associated with embryo quality or live birth. Only patient age had a strong ability to predict live birth.

Conclusion(s): The FMR1 repeat length is associated with ART response, but only weakly. It provides no incremental predictive ability beyond the conventionally used predictors, including patient age, antimüllerian hormone concentration, antral follicle count, and follicle-stimulating hormone level. These data suggest a possible role of the FMR1 repeat length within the normal range in ovarian response but demonstrate no clinically relevant indication for testing FMR1 as a predictor of ART outcomes.

Keywords: ART; CGG repeats; FMR1; IVF; ovarian reserve.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Scatter plots demonstrating the weak association of (A) FMR1 short alleles and (B) FMR1 long alleles and oocyte yield, and the strong association of (C) antral follicle count and (D) antimüllerian hormone with oocyte yield.
FIGURE 2
FIGURE 2
Receiver operating characteristic (ROC) curves associating predictor variables with (A) poor ovarian response (<4 oocytes) and (B) hyper ovarian response (>15 oocytes). The area under the curve (AUC) is shown under each ROC curve to demonstrate the association of the predictor variable with the outcome. For demonstrative purposes, an unconventional graphic display is demonstrated, as negative predictive variables are shown as dropping below the 0.50 null line. Note the further the ROC line drifts from the 0.50 null line (either up or down), the stronger it was for predicting the outcome.
FIGURE 3
FIGURE 3
Graph demonstrating the incidence of the best embryo being good (blue), fair (red), or poor (green) for (A) cleavage embryo transfers and (B) blastocyst embryo transfers/blastocyst freezing cycles.

References

    1. Usdin K, Kumari D. Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders. Front Genet 2015;6:192. - PMC - PubMed
    1. Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008;60:201–14. - PMC - PubMed
    1. Loesch D, Hagerman R. Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol 2012;769:78–114. - PMC - PubMed
    1. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identifi cation of a gene (FMR-1) containing a CGG repeat coincident with a break-point cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905–14. - PubMed
    1. Santoro MR, Bray SM, Warren ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 2012;7:219–45. - PubMed

Publication types

Substances